Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP618557.RAR0NVAkxiu8Ux5kuyHxNqCQDn2PO6Es8zqCykO31CuZE130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618557.RAR0NVAkxiu8Ux5kuyHxNqCQDn2PO6Es8zqCykO31CuZE130_provenance.
• NP353765.RABIaQ1Uqrdo-7b9a6IUJ2fCicpkrD_wv0DeakqfjHE9g130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353765.RABIaQ1Uqrdo-7b9a6IUJ2fCicpkrD_wv0DeakqfjHE9g130_provenance.
• NP581939.RA09OWQcSCIcnKY7IgZ-_BIjIsw4pUaOAKz_sCNoOkclU130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581939.RA09OWQcSCIcnKY7IgZ-_BIjIsw4pUaOAKz_sCNoOkclU130_provenance.
• NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.
• NP534898.RAJWJuWEqKinLR53-B1nYUIVT0FiPmX5bV3L-0uCRPiuo130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534898.RAJWJuWEqKinLR53-B1nYUIVT0FiPmX5bV3L-0uCRPiuo130_provenance.
• NP353729.RAfcLEkz3A6ny1Yp3baNBNhJtdnmif_qXQQL5DWzpQ6mE130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353729.RAfcLEkz3A6ny1Yp3baNBNhJtdnmif_qXQQL5DWzpQ6mE130_provenance.